Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
Article first published online: 8 AUG 2005
Journal of Neurochemistry
Volume 95, Issue 2, pages 437–445, October 2005
How to Cite
Maresz, K., Carrier, E. J., Ponomarev, E. D., Hillard, C. J. and Dittel, B. N. (2005), Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. Journal of Neurochemistry, 95: 437–445. doi: 10.1111/j.1471-4159.2005.03380.x
- Issue published online: 12 SEP 2005
- Article first published online: 8 AUG 2005
- Received April 8, 2005; revised manuscript received June 7, 2005; accepted June 10, 2005.
- central nervous system;
- experimental autoimmune encephalomyelitis;
- microglial cells;
- multiple sclerosis
The cannabinoid system is known to be important in neuronal regulation, but is also capable of modulating immune function. Although the CNS resident microglial cells have been shown to express the CB2 subtype of cannabinoid receptor during non-immune-mediated pathological conditions, little is known about the expression of the cannabinoid system during immune-mediated CNS pathology. To examine this question, we measured CB2 receptor mRNA expression in the CNS of mice with experimental autoimmune encephalomyelitis (EAE) and, by real-time PCR, found a 100-fold increase in CB2 receptor mRNA expression during EAE onset. We next determined whether microglial cells specifically express the CB2 receptor during EAE, and found that activated microglial cells expressed 10-fold more CB2 receptor than microglia in the resting state. To determine the signals required for the up-regulation of the CB2 receptor, we cultured microglial cells with combinations of γ-interferon (IFN-γ) and granulocyte) macrophage-colony stimulating factor (GM-CSF), which both promote microglial cell activation and are expressed in the CNS during EAE, and found that they synergized, resulting in an eight to 10-fold increase in the CB2 receptor. We found no difference in the amount of the CB2 receptor ligand, 2-arachidonylglycerol (2-AG), in the spinal cord during EAE. These data demonstrate that microglial cell activation is accompanied by CB2 receptor up-regulation, suggesting that this receptor plays an important role in microglial cell function in the CNS during autoimmune-induced inflammation.